Ropeginterferon alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes

doi:10.5306/wjco.v16.i10.112392

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

(64)

(62)

(0)

(1222)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Clin Oncol. Oct 24, 2025; 16(10): 112392
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.112392

Full Size Figure Download Figure

Figure 2 Forest plots of clinical outcomes. A: Complete hematological response; B: Molecular response; C: Adverse effects leading to discontinuation; D: JAK2V617F allele burden; E: Thrombotic events; F: Number of phlebotomies per patient per year. RI: Ropeginterferon alfa-2b; ST: Standard therapy; 95%CI: 95% confidence interval.

Citation: Tom L, Mani S, Rawat A, Nan M, Mundada SM, Al Khatib B, Gopinath A, Taj O, Salahuddin N, Shaju F, Parsa S, Abdurrahman M, Das A, Khawar MMH, Sher A. Ropeginterferon alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes. World J Clin Oncol 2025; 16(10): 112392
URL: https://www.wjgnet.com/2218-4333/full/v16/i10/112392.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i10.112392

Tom L, Mani S, Rawat A, Nan M, Mundada SM, Al Khatib B, Gopinath A, Taj O, Salahuddin N, Shaju F, Parsa S, Abdurrahman M, Das A, Khawar MMH, Sher A. Ropeginterferon alfa-2b vs standard therapy in polycythemia vera: A meta-analysis of efficacy and safety outcomes. World J Clin Oncol 2025; 16(10): 112392 [PMID: 41178922 DOI: 10.5306/wjco.v16.i10.112392]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.